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Introduction 
Special Care Dentistry (SCD) provides holistic oral service provision for people with complex 
health and care needs.1 These can include physical, sensory, intellectual, mental, medical, 
emotional or social impairment or disability or, more often, a combination of these factors. As 
a result, the remit of SCD is broad and covers a heterogeneous population group. The level 
of disability within these population groups can also vary and a proportion of people will have 
multiple and overlapping impairments and/or medical conditions.2 From a clinical 
perspective, it can often require “a holistic approach that is specialist led in order to meet the 
complex requirements of people with impairments”.3 It can also require a highly tailored 
approach, where the individual’s clinical needs are carefully considered alongside the 
patient’s expressed and wider medical, health and care needs. 
 
Given the importance of these elements, it could be argued that it requires a more 
considered approach to the generation and use of research evidence. This is challenging as 
the academic literature for this heterogenous population group is not as mature as it is for 
those without disability and impairment. Over the last ten years, very few large-scale trials or 
studies have been undertaken in SCD.4 Currently, there is only one trial that is looking at the 
effect of a high fluoride toothpaste in a potentially relevant population group, but this is likely 
to only form a small proportion of those that will be eventually recruited.5 Equally, the role of 
context in oral care for people living with disability and impairment is key. An intervention or 
approach that might work with one patient, may not work with another, given the need to 
account for other personal, clinical, emotional, medical and environmental factors. This 
poses a challenge, as we know in the broader literature that there is generally “not enough 
contextual information provided to transfer the results from the trial setting into other 
settings”.6 The role of context can also be stripped out further by the process of evidence 
synthesis. As Northridge & Metcalf highlight, there is a “need to extract the core issues from 
the context in which they are embedded in order to better ensure that they are transferable 
across settings”.7 As a result, this paper explores a number of possible research methods 
that may better reflect the diversity and challenges of this population group, where the 
emphasis is placed on co-production and co-design i.e. where research is carried out with 
evidence-users “rather than to, about or for them”.8 
  
Importance of co-production 
Understanding evidence-users’ needs and the challenges of improving health and well-being 
is important.9 Greenhalgh et al. argue that the best way to ensure that evidence is used is to 
co-create knowledge, drawing on the principles of co-production.10 As Langley et al. 
highlight, co-production in this sense adopts an inductive paradigm of partnership working, 
positioning research as a creative enterprise that has human experience at its core, whilst 
paying attention to the quality of relationships within the resulting partnership.10,11 Using 
facilitative methods, this approach is argued to bridge the gap between knowledge 
producers and knowledge users and would appear to offer some promise for SCD.12  
 
Inherently, co-production and co-creation challenges pre-determined, structural and often 
unstated assumptions around power and helps to ameliorate epistemiological injustice i.e. it 
challenges just who is allowed to control the knowledge agenda.13 As Langley et al. 
highlights, each stakeholder group (e.g. people with disability and/or impairment, clinicians, 
commissioners and researchers) will bring “different cognitive and emotional representation 
on [an] issue, shaped by different experiences and interests”.14 As a result, “a shared 
understanding of the nature of research and potential contributions to the research process 
has [….] to be considered within a dynamic context of different stakeholders’ mental models, 
which can be used to deconstruct and advance the knowledge problem towards potential 
solutions”.14,15 This paper will discuss three approaches to co-production in three key areas: 
1) Developing the research agenda; 2) Developing the intervention; and 3) Developing 
measures for evaluation. Each will be detailed briefly to elaborate on an earlier paper, using 
examples from on-going work in the area.16  
 
1) Developing the research agenda 
Priority Setting Partnerships (PSPs) are based on a consensus methodology and were 
developed initially by the James Lind Alliance to determine the most pressing research 
issues for any given population group. More specifically, they “promote discussion 
about how patients, clinicians and policy-makers should respond to uncertainties about the 
effects of treatments”.17,18 PSPs use a modified Nominal Group Technique which builds 
consensus across a range of stakeholders, ensuring the narratives of knowledge users 
(patients, clinicians and commissioners) are heard alongside those of knowledge producers 
(researchers).19 As such, they help to ensure that research agendas are built on the needs 
of the former, rather than being dictated by the latter.  
 
One example of this approach is the on-going PSP being undertaken by the NIHR Specialty 
Leads in oral health across the United Kingdom (UK).20 The aim of this PSP is to “identify 
the unanswered questions related to Oral and Dental Health from patient and clinical 
perspectives and then prioritise those that patients and clinicians agree are the most 
important”. One extension of this approach would be to run a PSP specifically for the 
population groups cared for by SCD, as the careful and thoughtful use of creative 
approaches can allow people (like many patients in SCD) who are normally excluded from 
such activities to be heard. A similar approach for dependent older people was piloted in 
2015 in both the UK and The Netherlands.21,22 A summary of these two PSPs has recently 
been reported and the outcomes framed using Maxwell’s taxonomy on quality.23 Key 
stakeholders were asked to explore a series of stem questions for discussion and present 
their views, which were discussed in four separate groups (users of services, carers of users 
of services, clinicians and care home staff). A shared ranking exercise was then undertaken 
after further structured small group discussions. Based on the Nominal Group Technique, 
each group took part in a facilitated discussion to identify key local priorities, which are 
provided in detail in the three published papers.21-23   
 
2) Developing the intervention  
As highlighted by Langley, “design is both a practice and a process”.11 Design helps to make 
ideas tangible, develop practical and attractive propositions to evidence-users and is 
particularly suited to complex, ill-defined, involving stakeholders with different 
perspectives.24,25 Co-design has an emphasis on process, where facilitation and co-creation 
brings different participants together to elicit and share their experience and perspectives.26 
Co-design recognises that stakeholders can bring both explicit and tacit knowledge and that 
working together in a group can help surface the latter and create new shared meaning that 
remains visible to all stakeholders through-out the process (given the “on-going physical 
presence of the prototypes”).11 
 
One relevant example here is the use of “Experience-Based Co-Design” (EBCD). In a NIHR 
funded study, researchers from Manchester, Bangor and Northumbria Universities are 
developing a STroke friendly Oral health Promoting (STOP) toolkit to improve oral self-care 
practices after discharge from hospital stroke services. Dental disease is highly prevalent in 
people with stroke and there is growing evidence of a potential shared inflammatory 
pathway.27 People who have suffered from a stroke have higher levels of both dental caries 
and periodontal disease and common risk factors such as smoking.28 Survivors of stroke 
tend to have fewer teeth, compared to the rest of the population and often wear dentures.29 
Xerostomia is common due to stroke related medication, which can further significantly 
increase the risk of tooth decay, periodontal disease, oral infection (e.g. oral thrush) and 
impact negatively upon wearing dentures.30 In turn, poor oral health has been linked with 
important sequelae of stroke, such as aspiration pneumonia, reduced quality of life and poor 
nutritional status.31 
 
EBCD is an approach that puts users at the centre of the design process by first capturing 
their experiences of care and then uses summaries of these experiences to develop new 
interventions or pathways.32,33 In the STOP toolkit study, researchers are first using 
qualitative interviews to understand the dental care experiences of stroke survivors, how 
they manage oral self-care practices, the context of the proposed intervention and what 
‘ideal’ would look like. These experiences are being captured on video and then a trigger film 
will be created to relay ‘touch-points’ (points in the interview that are imbued with affect or 
that have an identified ‘key-ness’), in readiness for the design stage. 
 
At the design stage, evidence-users (stroke sufferers, their carers, clinicians and 
commissioners) and evidence-producers will be brought together in four stages to develop 
the toolkit. The facilitators of the EBCD workshops will collate the expressed needs of stroke 
patients, along with their preferences and contributions. These will be represented on wall 
charts and flip-charts to co-create, in real time, a thematically organised map of the group’s 
thoughts, including important areas to aid in the development of the toolkit. The information 
will then be photo-documented and used to inform the toolkit’s content (e.g. education, 
information provision, sign-posting) and its format (design, layout, accessibility and 
availability). These will then be based on APEASE criteria (Affordability, Practicability, 
Effectiveness and cost-effectiveness, Acceptability, Side-effects/safety and Equity).34 
 
3) Developing measures for evaluation  
Using co-production to develop the research agenda and to design new interventions are 
two important areas that are of potential relevance for SCD. Another important area where 
co-production is important is in determining the types of outcome measures that are used 
when we evaluate the effectiveness of interventions, based on an experimental or quasi-
experimental design. As highlighted by Kirkham et al., there is “growing recognition that 
insufficient attention has been paid to the outcomes measured in clinical trials, which need to 
be relevant to health service users and other people making choices about health care if the 
findings of research are to influence practice and future research”.35 As a result, Core 
Outcome Sets, which account for the views of evidence-users is increasingly being 
recognised as an important step-forward. Recent standards have been published to guide 
the development of COSs (COnsensus-based Standards for the selection of health 
Measurement Instruments (COSMIN); and Core Outcome Set–STAndards for Reporting 
(COS-STAR) Statement).33,36 The COMET (Core Outcome Measures in Effectiveness Trials) 
initiative brings together people interested in the development and application of agreed 
standardised sets of outcomes, and holds an online database of planned, ongoing and 
completed work. 
 
One example here that is relevant for SCD, is the study being run by researchers from 
Queens University Belfast, alongside Bangor, Glasgow and Newcastle Universities and 
University College London: “DEvelopment of a Core outcome set for orAl health services 
research involving DEpendent older adults (DECADE)”.37 This study will build on the PSP 
identified above, which was used to set the research agenda, alongside an Effectiveness 
Practice and Organisation of Care Cochrane review.38 These will be used to develop an 
initial set of opening questions for qualitative interviews with dependent older people, their 
carers, care-home staff, clinicians and commissioners of NHS services.20 The interviews will 
then be transcribed and undergo thematic analysis. At the consensus stage, the different 
stakeholders will be asked to score each outcome from a long list of identified outcome 
measures gleaned from the systematic review and the previous stages of the process. This 
will be undertaken in stages, similar to processes already utilised in dentistry.39 Subsequent 
approaches for the final selection of the COS include the scale proposed by GRADE: 1 to 3 
signifies an outcome of limited importance, 4 to 6 important but not critical, and 7 to 9 critical. 
 
A number of rounds across multiple stakeholder groups will be held, using the GRADE 
criteria. This will enable the research team to summarise the responses and feed this back 
to the stakeholder groups to produce a refined version. To be consistent with the approach, 
an outcome will be included in the COS if more than 70% of the stakeholders score the 
measure between 7 to 9 and if fewer than 15% of the stakeholders score it as 1 to 3. 
Equally, consensus that an outcome is not included in the COS will be defined as 70% or 
more scoring it as 1 to 3 and fewer than 15% scoring it as 7 to 9.40 
 
Summary 
Given the complex requirements of people with disability and impairments and the holistic 
and tailored approach to clinical management that is commonly necessary, it would appear 
that co-production has much to offer SCD. Three brief examples have been provided that 
outline how such an approach may help in the generation and use of research evidence. All 
adopt an inductive paradigm of partnership working, positioning research as a creative 
enterprise that has human experience at its core. Using facilitative methods in the 
development of research agendas, intervention development and outcome measurement 
helps to narrow the gap between knowledge producers and knowledge users, whilst 
heralding an approach that ensures that the experiences and knowledge of all stakeholders 
are considered equally. 
 
In the first example, issues around power were addressed by using different stakeholder 
groups to set the initial priorities at separate meetings. These were then refined at a final 
meeting which contained representatives of each of these groups, but chaired by a patient 
representative to ensure the views of users of services were given weight. In the second 
example, the design of the intervention will again be considered by individual groups during 
the first iteration of the toolkit, with stroke patients themselves driving the note-making and 
collation process. Clinicians and commissioners of care will input into the design stage in 
separate groups undertaken concurrently, but again, the pooling of the different ideas from 
the different groups will be steered by stroke patient representatives in the final 
amalgamated group and the subsequent meetings. The use of patients in the development 
of COSs is now fully recognised and the explanatory document accompanying the COS-
STAR statement has multiple references to end users of services to ensure that their views 
are represented.41 In Rheumatology research, the explicit inclusion of patients in the 
development of COS has “significantly influenced outcome research in the field […] 
identifying new domains that are important for patients, and provided the patient 
perspective”.42 Overall, this has “led to wider patient involvement as partners in research” 
and now is being used in 81% of trials on the ClinicalTrials.gov database, two pertinent 
goals for research in SCD.42,43 
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